AccuSift provides high‑performance 4‑CPAHD (a major metabolite of nitrofurantoin) competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.4‑CPAHD (4‑chlorophenyl‑2‑aminohydantoin) is a primary metabolite of nitrofurantoin, a nitrofuran drug. Nitrofurantoin is rapidly metabolized in the body, making the parent drug difficult to detect. However, the metabolite 4‑CPAHD binds to tissue proteins, forming stable residues. Detection of 4‑CPAHD is used to indirectly assess exposure to the drug.Both the EU and China prohibit the presence of nitrofurantoin residues in animal‑derived foods. Detection of 4‑CPAHD is a key method for monitoring compliance with this ban.Performance Characteristics:
Sensitivity: ELISA IC50: 0.2 ppb; Colloidal Gold: 0.5 ppb
Source: Mouse Monoclonal Antibody
Recommended Pairing: (Coating) / (Labeling)
Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.
WeChat
